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Summary. A human genomic fragment comprising the 
cellular etinoic acid binding protein (CRABP) gene was 
isolated. By using a panel of somatic ell hybrids, this 
gene could be assigned to human chromosome 15. Sub- 
sequently, a possible involvement ofthe CRABP gene in 
translocation (15;17) (q22;q11) positive acute promyelo- 
cytic leukemia (APL) was investigated. Although trans- 
position of the CRABP gene could be demonstrated, we
did not observe any gross CRABP rearrangement i  a 
series of primary APL patients, nor in the acute myelo- 
blastic leukemia cell line HL-60. Thus, the observed lack 
of CRABP expression i these leukemic ells may not be 
caused by disruption of its gene. CRABP maps to the re- 
gion 15q22-qter. 
Introduction 
Retinoic acid (RA), a biologically active metabolite of 
retinol (vitamin A), plays an important role in various 
growth and differentiation processes during both embry- 
onic development and adult life (Lotan 1980; Omori and 
Chytil 1982; Chytil 1984; Oikarinen et al. 1985). RA has 
also been reported to induce in vitro differentiation of
cancerous cells, including human and murine embryonal 
carcinoma cells (Strickland and Mahdavi 1978; Andrews 
et al. 1986), the acute myeloblastic leukemia cell line 
HL-60, the monoblastic leukemia cell line U-937 (Breit- 
man et al. 1980; Hozumi 1982; Dalton et al. 1988) and 
blasts from acute myeloid leukemia (AML) patients in 
primary culture (Breitman et al. 1981; Honma et al. 
1983). Consequently, RA has on various occasions been 
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suggested as a potent agent for the treatment ofAML, in 
particular acute promyelocytic leukemia (APL) patients 
(Breitman et al. 1981; Meng-er et al. 1988; Hassan and 
Rees 1990). 
The molecular mechanisms underlying RA action are 
currently the subject of intensive investigations. Recent 
work indicates that RA acts as an endogenous signal that 
regulates gene expression via nuclear eceptors (RARs) 
in a dose-dependent way (Edwards and McBurney 1983; 
Evans 1988). The discovery of an RA gradient in the 
developing embryo by Thaller and Eichele (1987) is in 
full agreement with this notion. In addition to these 
nuclear receptors, cellular (cytoplasmic) RA-binding 
protein (CRABP) seems to play a role in RA-mediated 
signal transduction. During embryonic development, the 
spatial and temporal expression of the CRABP gene 
appears to be strictly regulated (Vaessen et al. 1989, 
1990; Perez-Castro et al. 1989; Maden et al. 1988, 
1989a). Hence, it has been suggested that CRABP could 
be involved in the formation of gradients of RA across 
various developing tissues (Maden et al. 1989b). 
Here, we report he isolation of the human homolog 
of the CRABP gene and its chromosomal localization. 
Subsequently, a possible involvement of CRABP in the 
APL specific translocation (15;17) (q22;q11) (Larson et 
al. 1984) was evaluated. Interestingly, although both 
primary APL cells and the acute myeloblastic leukemia- 
derived cell line HL-60 are responsive to differentiation- 
induction by RA, they seem to be deficient in the cellular 
RA-binding protein (Douer and Koeffler 1982; Jetten et 
al. 1987; Allegretto et al. 1983; Largman et al. 1989; 
C. Chomienne, personal communication). By using our 
newly isolated CRABP probe, we have studied its ex- 
pression at the RNA level in HL-60 cells prior to and 
after differentiation-induction. 
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Materials and methods 
Cells and culture conditions 
The panel of human-rodent hybrid cell lines used for the chromo- 
somal ocalization of the CRABP gene has been described before 
(Geurts van Kessel et al. 1983), as have the t(15;17)-derived cell 
hybrids C73/PJT2A1 and P12.3B6 (Sheer et al. 1983; van Tuinen 
et a1.1987). The hybrid (and parental) cells were grown in F10 or 
DMEM medium according to standard procedures. Chromosome 
analyses, using GTG-banding or R-banding after heat denatura- 
tion, and DNA extractions were carried out on the same batches of 
cells. 
HL-60 cells were cultured in RPMI-1640 medium supple- 
mented with 10% fetal calf serum, glutamine (2 mM), penicillin 
(100 U/ml) and streptomycin (100 gg/ml). After addition of 10-6M 
all-trans RA (from a 3 mg/ml stock in dimethyl sulfoxide; DMSO) 
or 1% DMSO, the cells were allowed to differentiate for 6 days 
(Breitman et al. 1980). During this period, the medium was 
replenished twice. As estimated from May Gr0nwald-Giemsa 
stained cytospin preparations, over 70% of the cells had differen- 
tiated into granulocytes and monocytes, respectively. 
Origin of the human CRABP probe 
Screening of a human genomic phage library (CMLO, kindly pro- 
vided by Dr. G. Grosveld) with mouse and chicken CRABP cDNA 
probes (Vaessen et al. 1989, 1990) yielded several CRABP-posi- 
tive clones. A 700-bp repeat-free human XhoII fragment was sub- 
cloned into the BamHI site of pTZ18R and its nucleotide sequence 
was determined via the dideoxy chain termination method (Sanger 
et al. 1977). 
Southern analysis 
DNAs were extracted according to standard procedures (J ffreys 
and Flavell 1977). Following cleavage with restriction enzymes, 
DNA fragments were s parated by electrophoresis onagarose gels 
and transferred to Genescreen (NEN) filters (Southern 1975). The 
human CRABP probe used was labeled with 32p using random 
priming as described by Feinberg and Vogelstein (1983). Hybrid- 
izations were carried out overnight at 65~ in the presence of 
0.5 M phosphate, 7% SDS and i mM EDTA. Filters were washed 
at 65~ 3 x 5 rain, in 40mM phosphate/0.1% SDS, followed by a 
30-min wash in 10mM phosphate 0.1% SDS. X-ray films were 
exposed using intensifier screens. 
Northern analysis 
Total RNA was isolated from cell lines using the LiC1/urea method 
described by Auffray and Rougeon (1980), electrophoresed on 1% 
agarose gels in the presence of formaldehyde, and transferred to 
Genescreen filters (Maniatis et al. 1982). Prior to electrophoresis, 
ethidium bromide was added to the RNA samples in order to allow 
visualization of the ribosomal RNAs in the gel (Fourney et al. 
1989). Probe labeling, hybridization (in the presence of 10% dex- 
tran sulfate) and washing conditions were essentially as described 
above. 
Results and discussion 
A 700-bp repeat-free human XhoII CRABP fragment 
was subcloned into the Bam-Hl site of pTZ18R and its 
nucleotide sequence was determined (details will be 
published elsewhere). Comparison of this sequence with 
the murine cDNA sequence revealed a 92% homology 
in the coding region from nucleotide 380 to 464 (num- 
Fig.1. Southern blot analysis of EcoRl-digested normal human 
fibroblast (a), myeloblastic leukemia cell line HL-60 (b), chromo- 
some-15-only somatic ell hybrid HORL-1 (c), 15/17 translocation- 
derivative positive hybrid C73/PJT2A1 (d), 17/15 translocation- 
derivative positive hybrid P12.3B6 (e) and control mouse (f) 
DNAs, after hybridization with the human CRABP probe. The 
slow migrating (> 10kb) bands (b, c) are a result of incomplete 
digestions (not observed in other similarly obtained preparations). 
The indicated molecular weight markers are derived from co-elec- 
trophoresed PstI-digested bacteriophage lambda DNA (in kb) 
bering according to Vaessen et al. 1989). Nucleotide 464 
represents an exon/intron boundary,  which is apparently 
conserved in the human and bovine genome (Shubeita et 
al. 1987). Comparison of the predicted amino acid se- 
quence revealed that our human clone codes for a pro- 
tein identical to CRABP from other species (bovine: 
Shubeita et al. 1987; mouse: Vaessen et al. 1989). Hence, 
the 700-bp subclone was named HuCRABP and used as 
a human CRABP-specif ic probe in the present study. 
For the chromosomal ocalization of the human 
CRABP gene, a panel of 19 well-defined (Geurts van 
Kessel et al. 1983) human-rodent somatic cell hybrids 
was used. High molecular weight DNA extracted from 
these cells and control rodent (hamster, mouse) and 
human cells was cleaved with EcoR1 and, after Southern 
blotting, analyzed for the presence of CRABP sequences 
using HuCRABP DNA as a probe. This probe hybrid- 
izes to a human EcoR1 fragment of approximately 10 kb 
(see Fig. 1) and does not hybridize to mouse or hamster 
DNA under the stringency conditions used. A high con- 
cordancy score (95%) was observed for chromosome 15 
(Table 1), whereas for all other human chromosomes, 
concordancy scores were invariably lower. Therefore, 
we conclude that the CRABP gene must reside on 
human chromosome 15. The only discordant clone (see 
Table 1) had retained chromosome 15 in a low percent- 
age of cells (10%). This assignment is not in agreement 
with a previous report in which a bovine cDNA was used 
as a probe under low stringency conditions (Nilsson et al. 
1988). The most likely explanation for this descrepancy 
is that the previously observed hybridization signals 
were the result of cross-hybridization of the bovine 
probe with a related gene(s) on human chromosome 3. 
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Table 1. Correlation between the presence or absence of human 
chromosomes and the CRABP gene in 19 human-rodent somatic 
cell hybrids 
Chromosome Chromosome/CRABP;no. ofclones Discordancy 
+/+ +/ -  - /+ - / -  (%) 
1 4 5 6 4 58 
2 2 2 8 7 53 
3 5 4 5 5 47 
4 6 3 4 6 37 
5 5 5 5 4 43 
6 5 4 5 5 47 
7 5 2 5 7 37 
8 7 6 3 3 47 
9 6 6 4 3 53 
10 3 4 7 5 58 
11 4 5 6 4 58 
12 7 2 3 7 26 
13 7 5 3 4 42 
14 8 5 2 4 37 
15 10 1 a 0 8 5 
16 7 6 3 3 47 
17 9 5 1 4 32 
18 4 5 6 4 58 
19 7 5 3 4 42 
20 9 7 1 2 42 
21 7 7 3 2 53 
22 7 6 3 3 47 
X 6 2 4 7 32 
a This hybrid clone contains chromosome 15 in a low percentage 
of cells (10%) 
In order to establish the localization of the CRABP 
gene relative to the acute promyeolocytic leukemia 
(APL)-associated t(15;17)(q22;qll) breakpoint on chro- 
mosome 15, hybrid cell lines derived from the fusion of 
cells from two t(15;17)-positive APL  patients, having 
retained either the 15/17 or the 17/15 translocation 
derivative in the absence of a normal chromosome 15, 
were subjected to Southern blot analysis. A human- 
chromosome-15-only hybrid (HORL-1,  N. Spurr unpub- 
lished result), normal human fibroblasts and the acute 
myeloblastic leukemia cell line HL-60 were also included 
in this analysis. Figure 1 shows that HORL-1 (lane c) is 
positive for CRABP;  this confirms our localization of 
this gene on human chromosome 15. Similarly hybridiz- 
ing EcoR1 fragments were found in normal human fibro- 
blast (lane a) and HL-60 (lane b) DNAs, indicating that 
no gross rearrangements have occurred in this CRABP 
sequence in the leukemic cell line HL-60. Hybrid C73/ 
PJT2A1 (lane d), which contains the 15/17 derivative of 
the t(15;17), is negative, whereas P12.3B6 (lane e) con- 
taining the 17/15 derivative of this translocation is posi- 
tive for CRABP.  From these results, we conclude that, 
as a result of the t(15,17), CRABP is transposed from 
chromosome 15 to chromosome 17 in APL. As in HL-60 
DNA,  the APL-derived hybrids show no aberrantly hyb- 
ridizing fragments. Similar results were obtained with 
BamHI-cleaved (hybrid) DNAs. In addition, DNAs 
from another eight t(15;17)-positive APL  patients were 
tested for the presence of gross rearrangements in the 
CRABP gene via EcoR1 or BamH1 digestion and 
Southern blotting. Again, no aberrantly hybridizing 
fragments were observed (not shown). Apparently, the 
break in t(15;17) positive APL  does not occur within re- 
striction fragments hybridizing to our CRABP probe. 
Previously, it was reported that, at the protein level, 
no CRABP expression could be detected in the myelo- 
blastic leukemia-derived cell line HL-60 (Douer and 
Koeffier 1982; Jetten et al. 1987; Largman et al. 1989). 
In order to extend these studies to the RNA level, a 
Northern blot analysis was carried out using RNA ex- 
tracted from exponentially growing HL-60 cells and 
HL-60 cells that were induced to differentiate for 6 days 
using 10 -6 M all-trans RA (granulocytic differentiation) 
or 1% DMSO (monocytic differentiation) according to 
standard protocols (Breitman et al. 1980). By using 
HuCRABP as a probe, no CRABP transcripts could be 
detected in any of the HL-60 derived RNAs (not 
shown). DMSO induction of CRABP was previously ob- 
served in a murine embryonal carcinoma (EC) cell sys- 
tem (Vaessen et al. 1989). In HL-60 cells, however, 
DMSO exposure does not result in expression of detect- 
able amounts of CRABP mRNA.  A positive CRABP 
signal was observed in a co-electrophoresed RNA sam- 
ple extracted from the human EC cell line N-Tera 2 
(Andrews et al. 1986). Since the CRABP gene does not 
seem to be grossly disrupted in HL-60 cells (or primary 
APL samples), lack of CRABP expression in these cells 
may be caused by transcriptional repression. 
In conclusion, we have isolated genomic fragments 
corresponding to the human CRABP gene. Subsequent- 
ly, this gene could be localized on human chromosome 
15, distal to the APL-associated breakpoint (region 
15q22-ter). As a result of this translocation, the CRABP 
gene does not seem to be grossly rearranged. Further 
experiments are required to evaluate a possible role of 
CRABP in (aberrant) myeloid differentiation processes 
and the development of APL. 
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